• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
 
Trade NameRES-Q(TM) ARRHYTHMIA CONTROL DEVICE EPICARDIAL PATCH AND NON-THORACOTOMY LEAD (NTL) SYSTEMS
Classification Nameimplantable cardioverter defibrillator (non-crt)
Generic Nameimplantable cardioverter/defribrillator
ApplicantBOSTON SCIENTIFIC
PMA NumberP940008
Date Received03/17/1994
Decision Date11/28/1995
Withdrawal Date 07/20/2012
Product Code
LWS[ Registered Establishments with LWS ]
Docket Number 96M-0202
Notice Date 07/10/1996
Advisory Committee Cardiovascular
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval application (pma) for the res-q acd (arrythmia control device) epicardial patch and non-thoracotomy lead (ntl) systems which consist of the following: model 101-01 & 101-01r res-q implantable arrhythmia control device; model 531-30 rx2000 graphics program module to be used with intermedics commercially available model 522-06 rx2000 graphics programmer; models 497-05, 497-06, and 497-09 right ventricular (rv) defibrillation/pacing leads; model 497-15 subcutaneous patch lead; model 497-16 superior vena cava (svc) leads; models 497-01, 497-02, 497-11, and 497-12 epicardial patch leads; models a67 and l67 commercially available cpi epicardial patch leads; model 370-01 adapter; model 370-21 y-adapter; model 370-04 test box; models 370-03 and 370-23 patient cables; model 370-05 test load; model 370-02 accessory kit; model 370-10 lead caps; and models 370-11, 370-12, 370-13, 370-14, 370-15,370-16, 370-48, and 370-49 stylets. This device is indicated for use in patients who are at high risk of sudden death due to ventricular arrhythmias and have experienced one of the following situations: (1) survival of at least one episode of cardiac arrest (manifested by a loss of consciousness) due to a ventricular tachyarrhythmia, or (2) recurrent, poorly tolerated sustained ventricular tachycardia (vt).
Supplements: S001 S002 S003 S004 S005 S006 
S007 S008 S009 S012 S014 S015 
S016 S017 S018 S019 S020 S021 
S022 S025 S026 S027 S028 S029 
S030 
-
-